Login to Your Account



VALUATIONS THROUGH THE ROOF

Record year on capital markets; can the industry do it again?

By Peter Winter
Editor

Monday, January 13, 2014

The mood going into the start of the 32nd annual J.P. Morgan Healthcare Conference in San Francisco will be decidedly upbeat. How could it not be? The industry is just coming off one of its best performances in decades with many of the blue chip public biotech companies recording triple digit percentage gains in their share values.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription